Novo Nordisk news – The Milli Chronicle

Sunday, January 18, 2026

Latest:

Factual Version of a Story

NewsDesk Milli Chronicle January 14, 2026January 14, 2026 biotech growth outlook, diabetes care worldwide, diabetes treatment growth, drug market expansion, global drug demand, global health trends, global pharmaceutical markets, healthcare innovation, healthcare investment, international drug sales, international healthcare markets, life sciences industry, Novo Nordisk news, Novo Nordisk strategy, obesity market trends, obesity treatment innovation, pharma capacity expansion, pharmaceutical competition, pharmaceutical pipeline, weight loss drugs

Novo Nordisk Strengthens Global Strategy as International Markets Evolve

Novo Nordisk is navigating a shifting global healthcare landscape with confidence, focusing on innovation, capacity expansion, and long-term growth opportunities

Novo Nordisk and Eli Lilly Reject Claims of Partnership with Mangoceuticals on Obesity Drugs

Novo Nordisk and Eli Lilly clarify that they have no collaboration or special arrangement with telehealth firm Mangoceuticals, following misleading